Literature DB >> 36262742

Eligibility and Usage of Sacubitril/Valsartan in Korea.

Jin-Jin Kim1, Jong-Chan Youn1.   

Abstract

Entities:  

Year:  2019        PMID： 36262742      PMCID： PMC9536666          DOI： 10.36628/ijhf.2019.0008

Source DB:  PubMed          Journal:  Int J Heart Fail        ISSN： 2636-154X


× No keyword cloud information.
  10 in total

1.  Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.

Authors:  Chris J Kapelios; Mitja Lainscak; Gianluigi Savarese; Cécile Laroche; Petar Seferovic; Frank Ruschitzka; Andrew Coats; Stefan D Anker; Maria G Crespo-Leiro; Gerasimos Filippatos; Massimo F Piepoli; Giuseppe Rosano; Luisa Zanolla; Carlos Aguiar; Jan Murin; Przemyslaw Leszek; Theresa McDonagh; Aldo P Maggioni; Lars H Lund
Journal:  Eur J Heart Fail       Date:  2019-06-18       Impact factor: 15.534

2.  PIONEERing the In-Hospital Initiation of Sacubitril-Valsartan.

Authors:  John Jarcho
Journal:  N Engl J Med       Date:  2019-02-07       Impact factor: 91.245

Review 3.  Changing Provider Behavior in the Context of Chronic Disease Management: Focus on Clinical Inertia.

Authors:  Kim L Lavoie; Joshua A Rash; Tavis S Campbell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-09-07       Impact factor: 13.820

4.  Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.

Authors:  Akshay S Desai; John J V McMurray; Milton Packer; Karl Swedberg; Jean L Rouleau; Fabian Chen; Jianjian Gong; Adel R Rizkala; Abdel Brahimi; Brian Claggett; Peter V Finn; Loren Howard Hartley; Jiankang Liu; Martin Lefkowitz; Victor Shi; Michael R Zile; Scott D Solomon
Journal:  Eur Heart J       Date:  2015-05-28       Impact factor: 29.983

5.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

6.  Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Authors:  Milton Packer; John J V McMurray; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael Zile; Karl Andersen; Juan Luis Arango; J Malcolm Arnold; Jan Bělohlávek; Michael Böhm; Sergey Boytsov; Lesley J Burgess; Walter Cabrera; Carlos Calvo; Chen-Huan Chen; Andrej Dukat; Yan Carlos Duarte; Andrejs Erglis; Michael Fu; Efrain Gomez; Angel Gonzàlez-Medina; Albert A Hagège; Jun Huang; Tzvetana Katova; Songsak Kiatchoosakun; Kee-Sik Kim; Ömer Kozan; Edmundo Bayram Llamas; Felipe Martinez; Bela Merkely; Iván Mendoza; Arend Mosterd; Marta Negrusz-Kawecka; Keijo Peuhkurinen; Felix J A Ramires; Jens Refsgaard; Arvo Rosenthal; Michele Senni; Antonio S Sibulo; José Silva-Cardoso; Iain B Squire; Randall C Starling; John R Teerlink; Johan Vanhaecke; Dragos Vinereanu; Raymond Ching-Chiew Wong
Journal:  Circulation       Date:  2014-11-17       Impact factor: 29.690

Review 7.  Temporal Trends of Hospitalized Patients with Heart Failure in Korea.

Authors:  Jong-Chan Youn; Seongwoo Han; Kyu-Hyung Ryu
Journal:  Korean Circ J       Date:  2016-12-29       Impact factor: 3.243

8.  "Real World" Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry.

Authors:  Joanne Simpson; L Benson; P S Jhund; U Dahlström; J J V McMurray; L H Lund
Journal:  Cardiovasc Drugs Ther       Date:  2019-06       Impact factor: 3.727

9.  Update on heart failure management and future directions.

Authors:  Hong-Mi Choi; Myung-Soo Park; Jong-Chan Youn
Journal:  Korean J Intern Med       Date:  2018-12-28       Impact factor: 2.884

10.  Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF).

Authors:  Sang Eun Lee; Hae-Young Lee; Hyun-Jai Cho; Won-Seok Choe; Hokon Kim; Jin Oh Choi; Eun-Seok Jeon; Min-Seok Kim; Jae-Joong Kim; Kyung-Kuk Hwang; Shung Chull Chae; Sang Hong Baek; Seok-Min Kang; Dong-Ju Choi; Byung-Su Yoo; Kye Hun Kim; Hyun-Young Park; Myeong-Chan Cho; Byung-Hee Oh
Journal:  Korean Circ J       Date:  2017-05-25       Impact factor: 3.243
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.